404 related articles for article (PubMed ID: 27216237)
1. Microbiome of HIV-infected people.
Dubourg G; Surenaud M; Lévy Y; Hüe S; Raoult D
Microb Pathog; 2017 May; 106():85-93. PubMed ID: 27216237
[TBL] [Abstract][Full Text] [Related]
2. How can the gut microbiota affect immune recovery in HIV-infected individuals?
Serrano-Villar S; Ferrer M; Gosalbes MJ; Moreno S
Future Microbiol; 2017 Mar; 12():195-199. PubMed ID: 28262047
[No Abstract] [Full Text] [Related]
3. Inside Out: HIV, the Gut Microbiome, and the Mucosal Immune System.
Liu J; Williams B; Frank D; Dillon SM; Wilson CC; Landay AL
J Immunol; 2017 Jan; 198(2):605-614. PubMed ID: 28069756
[TBL] [Abstract][Full Text] [Related]
4. HIV-induced alteration in gut microbiota: driving factors, consequences, and effects of antiretroviral therapy.
Lozupone CA; Rhodes ME; Neff CP; Fontenot AP; Campbell TB; Palmer BE
Gut Microbes; 2014 Jul; 5(4):562-70. PubMed ID: 25078714
[TBL] [Abstract][Full Text] [Related]
5. HIV and the Gut Microbiota: Composition, Consequences, and Avenues for Amelioration.
Vujkovic-Cvijin I; Somsouk M
Curr HIV/AIDS Rep; 2019 Jun; 16(3):204-213. PubMed ID: 31037552
[TBL] [Abstract][Full Text] [Related]
6. Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals.
Vázquez-Castellanos JF; Serrano-Villar S; Latorre A; Artacho A; Ferrús ML; Madrid N; Vallejo A; Sainz T; Martínez-Botas J; Ferrando-Martínez S; Vera M; Dronda F; Leal M; Del Romero J; Moreno S; Estrada V; Gosalbes MJ; Moya A
Mucosal Immunol; 2015 Jul; 8(4):760-72. PubMed ID: 25407519
[TBL] [Abstract][Full Text] [Related]
7. Unique Gut Microbiome in HIV Patients on Antiretroviral Therapy (ART) Suggests Association with Chronic Inflammation.
Ishizaka A; Koga M; Mizutani T; Parbie PK; Prawisuda D; Yusa N; Sedohara A; Kikuchi T; Ikeuchi K; Adachi E; Koibuchi T; Furukawa Y; Tojo A; Imoto S; Suzuki Y; Tsutsumi T; Kiyono H; Matano T; Yotsuyanagi H
Microbiol Spectr; 2021 Sep; 9(1):e0070821. PubMed ID: 34378948
[TBL] [Abstract][Full Text] [Related]
8. Altered Gut Microbiota in HIV Infection: Future Perspective of Fecal Microbiota Transplantation Therapy.
Kang Y; Cai Y
AIDS Res Hum Retroviruses; 2019 Mar; 35(3):229-235. PubMed ID: 29877092
[TBL] [Abstract][Full Text] [Related]
9. Microbiota-Meditated Immunity Abnormalities Facilitate Hepatitis B Virus Co-Infection in People Living With HIV: A Review.
Ouyang J; Zaongo SD; Zhang X; Qi M; Hu A; Wu H; Chen Y
Front Immunol; 2021; 12():755890. PubMed ID: 35069530
[TBL] [Abstract][Full Text] [Related]
10. The effects of prebiotics on microbial dysbiosis, butyrate production and immunity in HIV-infected subjects.
Serrano-Villar S; Vázquez-Castellanos JF; Vallejo A; Latorre A; Sainz T; Ferrando-Martínez S; Rojo D; Martínez-Botas J; Del Romero J; Madrid N; Leal M; Mosele JI; Motilva MJ; Barbas C; Ferrer M; Moya A; Moreno S; Gosalbes MJ; Estrada V
Mucosal Immunol; 2017 Sep; 10(5):1279-1293. PubMed ID: 28000678
[TBL] [Abstract][Full Text] [Related]
11. Local and Long-Distance Calling: Conversations between the Gut Microbiota and Intra- and Extra-Gastrointestinal Tract Infections.
Denny JE; Powell WL; Schmidt NW
Front Cell Infect Microbiol; 2016; 6():41. PubMed ID: 27148490
[TBL] [Abstract][Full Text] [Related]
12. Microbiota and Probiotics in Health and HIV Infection.
D'Angelo C; Reale M; Costantini E
Nutrients; 2017 Jun; 9(6):. PubMed ID: 28621726
[TBL] [Abstract][Full Text] [Related]
13. Altered gut microbiome composition in HIV infection: causes, effects and potential intervention.
Bandera A; De Benedetto I; Bozzi G; Gori A
Curr Opin HIV AIDS; 2018 Jan; 13(1):73-80. PubMed ID: 29045252
[TBL] [Abstract][Full Text] [Related]
14. Gut Bacteria Metabolism Impacts Immune Recovery in HIV-infected Individuals.
Serrano-Villar S; Rojo D; Martínez-Martínez M; Deusch S; Vázquez-Castellanos JF; Bargiela R; Sainz T; Vera M; Moreno S; Estrada V; Gosalbes MJ; Latorre A; Seifert J; Barbas C; Moya A; Ferrer M
EBioMedicine; 2016 Jun; 8():203-216. PubMed ID: 27428431
[TBL] [Abstract][Full Text] [Related]
15. The impact of
Machiavelli A; Duarte RTD; Pires MMS; Zárate-Bladés CR; Pinto AR
Gut Microbes; 2019; 10(5):599-614. PubMed ID: 30657007
[TBL] [Abstract][Full Text] [Related]
16. Complexities of Gut Microbiome Dysbiosis in the Context of HIV Infection and Antiretroviral Therapy.
Li SX; Armstrong A; Neff CP; Shaffer M; Lozupone CA; Palmer BE
Clin Pharmacol Ther; 2016 Jun; 99(6):600-11. PubMed ID: 26940481
[TBL] [Abstract][Full Text] [Related]
17. The gut microbiome in human immunodeficiency virus infection.
Zilberman-Schapira G; Zmora N; Itav S; Bashiardes S; Elinav H; Elinav E
BMC Med; 2016 Jun; 14(1):83. PubMed ID: 27256449
[TBL] [Abstract][Full Text] [Related]
18. Gut barrier structure, mucosal immunity and intestinal microbiota in the pathogenesis and treatment of HIV infection.
Tincati C; Douek DC; Marchetti G
AIDS Res Ther; 2016; 13():19. PubMed ID: 27073405
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic avenues for restoring the gut microbiome in HIV infection.
Rosel-Pech C; Chávez-Torres M; Bekker-Méndez VC; Pinto-Cardoso S
Curr Opin Pharmacol; 2020 Oct; 54():188-201. PubMed ID: 33271427
[TBL] [Abstract][Full Text] [Related]
20. Gut epithelial barrier dysfunction in human immunodeficiency virus-hepatitis C virus coinfected patients: Influence on innate and acquired immunity.
Márquez M; Fernández Gutiérrez del Álamo C; Girón-González JA
World J Gastroenterol; 2016 Jan; 22(4):1433-48. PubMed ID: 26819512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
